|کد مقاله||کد نشریه||سال انتشار||مقاله انگلیسی||ترجمه فارسی||نسخه تمام متن|
|5736780||1613789||2017||6 صفحه PDF||سفارش دهید||دانلود رایگان|
- A new human model to study autism spectrum disorders.
- Advances on modeling monogenetic autisms.
- Efforts on modeling rare variants related to autism.
- The use of induced pluripotent stem cells derived neurons for drug screening.
Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders characterized by impaired social communication and interactions and by restricted and repetitive behaviors. Although ASD is suspected to have a heritable or sporadic genetic basis, its underlying etiology and pathogenesis are not well understood. Therefore, viable human neurons and glial cells produced using induced pluripotent stem cells (iPSC) to reprogram cells from individuals affected with ASD provide an unprecedented opportunity to elucidate the pathophysiology of these disorders, providing novel insights regarding ASD and a potential platform to develop and test therapeutic compounds. Herein, we discuss the state of art with regards to ASD modeling, including limitations of this technology, as well as potential future directions.This article is part of a Special Issue entitled SI: Exploiting human neurons.
Journal: Brain Research - Volume 1656, 1 February 2017, Pages 49-54